SG11201508796SA - Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method - Google Patents

Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method

Info

Publication number
SG11201508796SA
SG11201508796SA SG11201508796SA SG11201508796SA SG11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA SG 11201508796S A SG11201508796S A SG 11201508796SA
Authority
SG
Singapore
Prior art keywords
stem cell
induced pluripotent
pluripotent stem
produced
producing
Prior art date
Application number
SG11201508796SA
Other languages
English (en)
Inventor
Sang Yeon Lee
Won Ju Jung
Ho Bin Kim
Min Sun Oh
Kye Ho Lee
Original Assignee
Bbhc Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bbhc Co Ltd filed Critical Bbhc Co Ltd
Publication of SG11201508796SA publication Critical patent/SG11201508796SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1369—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11201508796SA 2013-11-01 2013-11-01 Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method SG11201508796SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2013/009845 WO2015064795A1 (ko) 2013-11-01 2013-11-01 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 및 그 방법에 의해 제조된 유도만능 줄기세포

Publications (1)

Publication Number Publication Date
SG11201508796SA true SG11201508796SA (en) 2015-11-27

Family

ID=53004383

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508796SA SG11201508796SA (en) 2013-11-01 2013-11-01 Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method

Country Status (16)

Country Link
US (1) US9938504B2 (da)
EP (1) EP3064572B1 (da)
JP (1) JP6700175B2 (da)
CN (1) CN105264066B (da)
CY (1) CY1123057T1 (da)
DK (1) DK3064572T3 (da)
ES (1) ES2790669T3 (da)
HR (1) HRP20200701T1 (da)
HU (1) HUE049567T2 (da)
LT (1) LT3064572T (da)
PL (1) PL3064572T3 (da)
PT (1) PT3064572T (da)
RS (1) RS60200B1 (da)
SG (1) SG11201508796SA (da)
SI (1) SI3064572T1 (da)
WO (1) WO2015064795A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101592401B1 (ko) * 2014-06-13 2016-02-05 주식회사 비비에이치씨 지방-유래 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 및 그 방법에 의해 제조된 유도만능 줄기세포

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100697326B1 (ko) * 2005-12-02 2007-03-20 재단법인서울대학교산학협력재단 Ｏｃｔ４ 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법
KR100792184B1 (ko) * 2006-05-12 2008-01-07 재단법인서울대학교산학협력재단 개의 제대혈, 태반 및 개 태아의 심장 유래 다분화능 성체줄기세포, 그 제조방법 및 이를 함유하는 세포 치료제
US20100135970A1 (en) * 2006-10-27 2010-06-03 Caritas St. Elizabeth Medical Center Of Boston, In Methods for Reprogramming Adult Somatic Cells and Uses Thereof
CN101748096B (zh) * 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
KR101016761B1 (ko) 2009-02-26 2011-02-25 부경대학교 산학협력단 피부 미백활성을 갖는 감태 추출물
KR100950195B1 (ko) * 2009-03-20 2010-03-29 서울대학교산학협력단 Ｚｎｆ281을 발현하는 제대혈 유래 만능 줄기세포의 분리방법
CA2756938C (en) * 2009-03-31 2017-01-31 The Board Of Regents Of The University Of Texas System Isolation of human umbilical cord blood-derived mesenchymal stem cells
JP2014133703A (ja) * 2011-03-30 2014-07-24 Clio Inc 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物
WO2011037301A1 (ko) 2009-09-22 2011-03-31 서울대학교병원 성체세포로부터 만능줄기세포를 유도하는 방법 및 그 방법에 의해 제조된 만능줄기세포
KR20120040488A (ko) 2010-10-19 2012-04-27 충남대학교산학협력단 곰피와 감태 추출물 유래의 플로로탄닌을 포함하는 화장품 조성물
CN103384680B (zh) * 2010-12-17 2015-08-26 拜奥拉米那公司 细胞培养基
KR101887956B1 (ko) 2011-08-10 2018-08-13 (주)아모레퍼시픽 효소 처리 감태 추출물을 포함하는 피부 미백용 조성물
KR101408106B1 (ko) 2011-12-30 2014-06-19 박영준 줄기세포 분화능 개선용 조성물
KR101542848B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 골아세포로 분화시키는 방법
KR101542850B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 지방세포로 분화시키는 방법
KR101542849B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 간세포로 분화시키는 방법
KR101542846B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 연골세포로 분화시키는 방법
KR101542847B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 신경세포로 분화시키는 방법
KR101699761B1 (ko) 2014-05-23 2017-01-25 주식회사 비비에이치씨 플로로탄닌 분획물을 이용한 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법
KR101592401B1 (ko) 2014-06-13 2016-02-05 주식회사 비비에이치씨 지방-유래 중간엽 줄기세포로부터 유도만능 줄기세포를 제조하는 방법 및 그 방법에 의해 제조된 유도만능 줄기세포

Also Published As

Publication number Publication date
EP3064572B1 (en) 2020-02-12
EP3064572A1 (en) 2016-09-07
JP2016521990A (ja) 2016-07-28
CN105264066B (zh) 2021-06-11
WO2015064795A1 (ko) 2015-05-07
JP6700175B2 (ja) 2020-05-27
US20160230146A1 (en) 2016-08-11
ES2790669T3 (es) 2020-10-28
PT3064572T (pt) 2020-05-07
LT3064572T (lt) 2020-07-27
SI3064572T1 (sl) 2020-08-31
US9938504B2 (en) 2018-04-10
DK3064572T3 (da) 2020-05-04
HRP20200701T1 (hr) 2020-12-11
HUE049567T2 (hu) 2020-10-28
CY1123057T1 (el) 2021-10-29
EP3064572A4 (en) 2017-03-22
RS60200B1 (sr) 2020-06-30
CN105264066A (zh) 2016-01-20
PL3064572T3 (pl) 2020-07-13

Similar Documents

Publication Publication Date Title
HK1222200A1 (zh) 製備多能幹細胞的方法
HK1219050A1 (zh) 免疫保護性原代間充質幹細胞和方法
HK1220487A1 (zh) 全能幹細胞的誘導方法、及用該方法製備的全能幹細胞
PL3064575T3 (pl) Sposób różnicowania pluripotentnych komórek macierzystych indukowanych z mezenchymalnych komórek macierzystych w hepatocyt
PL3064573T3 (pl) Sposób różnicowania pluripotentnych komórek macierzystych indukowanych z mezenchymalnych komórek macierzystych w neuron
LT3064574T (lt) Pluripotentinių kamieninių ląstelių, indikuotų iš mezenchiminių kamieninių ląstelių, diferenciacijos į chondrocitus būdas
SI3156481T1 (sl) Metoda za izdelavo induciranih pluripotentnih matičnih celic iz mezenhimskih matičnih celic, izvedenih iz maščobnega tkiva in induciranih pluripotentnih matičnih celic, izdelanih po isti metodi
EP3015551A4 (en) PROCESS FOR SCREENING FOR A FACTOR FOR SPREADING PLURIPOTENTAL STEM CELLS
PT3036321T (pt) Processo de produção de células tronco multipotentes e progenitores, células tronco e/ou progenitores, fragmentos de tecidos de nnct e concentrado de células tronco
HUE048416T2 (hu) Eljárás mezenchimális õssejtbõl indukált pluripotens õssejt oszteoblaszttá differenciáltatására
SG11201508796SA (en) Method for producing induced pluripotent stem cell from mesenchymal stem cell and induced pluripotent stem cell produced by the method
EP3040416A4 (en) Method for producing induced pluripotent stem cells